Pasar al contenido principal

INFLUENCIA DE EXOPOLISACARIDOS BACTERIANOS SINTETIZADOS EN PRODUCTOS LACTEOS EN LA BIODISPONIBILIDAD DE BIOACTIVOS

RTI2018-096339-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Molecules Produced by Probiotics and Intestinal Microorganisms with Immunomodulatory Activity

  • Delgado, Susana
  • Sánchez García, Borja
  • Margolles Barros, Abelardo
  • Ruas-Madiedo, Patricia
  • Ruíz García, Lorena
© 2020 by the authors., Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. The probiotic microorganisms most commonly used in the food and pharmacy industry belong to Lactobacillus and Bifidobacterium, and several strains of these genera have demonstrated beneficial attributes. In addition, some other intestinal bacteria inhabiting the human microbiota, such as Faecalibacterium prausnitzii and Akkermansia muciniphila, have recently been discovered and are able to display health-promoting effects in animal and human trials. The beneficial properties of probiotics have been known for a long time, although little is known about the molecular mechanisms and the molecules responsible for their effects. However, in recent years, advances in microbiome studies, and the use of novel analytical and molecular techniques have allowed a deeper insight into their effects at the molecular level. This review summarizes the current knowledge of some of the molecules of probiotics and other intestinal commensal bacteria responsible for their immunomodulatory effect, focusing on those with more solid scientific evidence., Funding in our group is supported by the grants IDI/2018/000236 from the Principality of Asturias, AGL2016-78311-R (AEI/FEDER UE) from the Ministry of Economy and Competitiveness (MINECO), and RTI2018-096339-B-I00 and RTI2018-095021-J-I00 (MCIU/AEI/FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Selection of Exopolysaccharide-Producing Lactobacillus Plantarum (Lactiplantibacillus Plantarum) Isolated from Algerian Fermented Foods for the Manufacture of Skim-Milk Fermented Products

  • Bachtarzi, Nadia
  • Speciale, Immacolata
  • Kharroub, Karima
  • Castro, Cristina De
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
© 2020 by the authors., The exopolysaccharide (EPS)-producing Lactobacillus plantarum (renamed as Lactiplantibacillus plantarum) LBIO1, LBIO14 and LBIO28 strains, isolated from fermented dairy products typical from Algeria, were characterized to evaluate the impact of the polymers in milk fermentations. Their genomes revealed the presence of two complete eps clusters of the four described for the reference strain WCFS1. Besides, the three strains presented identical sequences of eps3 and eps4 clusters, but LBIO1 and LBIO28 harbour three genes belonging to eps2 which are absent in the LBIO14 genome. The EPS purified from fermented skim-milks manufactured with the strains showed identical nuclear magnetic resonance (1H-NMR) and size exclusion chromatography coupled with a multiangle laser light scattering detector (SEC-MALLS) profiles for polymers LBIO1 and LBIO28, whereas LBIO14 EPS was different due to the lack of the high-molecular weight (HMW)-EPS and the absence of specific monosaccharide’s peaks in the anomeric region of its proton NMR spectrum. The presence of the HMW-EPS correlated with optimal sensorial-physical characteristics of the fermented skim-milks (ropy phenotype). Their microstructures, studied by confocal scanning laser microscopy (CSLM), also showed differences in the organization of the casein-network and the distribution of the bacteria inside this matrix. Therefore, the strain LBIO1 can be proposed for the manufacture of dairy products that require high whey retention capability, whereas LBIO28 could be applied to increase the viscosity., This research was funded by the grants RTI2018-096339-B-I00 (funded by MCIU/AEI/FEDER, UE), RTI2018-095021-J-I00 (funded by MCIU/AEI/FEDER, UE), and IDI/2018/000236 (funded by PCTI Gobierno del Principado de Asturias/ FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exopolysaccharide Producing Bifidobacterium animalis subsp. lactis Strains Modify the Intestinal Microbiota and the Plasmatic Cytokine Levels of BALB/c Mice According to the Type of Polymer Synthesized

  • Sabater, Carlos
  • Molinero, Natalia
  • Castro-Bravo, Nuria
  • Diez-Echave, Patricia
  • Hidalgo-García, Laura
  • Delgado, Susana
  • Sánchez García, Borja
  • Gálvez, Julio
  • Margolles Barros, Abelardo
  • Ruas-Madiedo, Patricia
Bacteria-host interactions are mediated by different microbial associated molecular patterns which are most often surface structures such as, among others, exopolysaccharides (EPSs). In this work, the capability of two isogenic EPS-producing Bifidobacterium animalis subsp. lactis strains to modulate the gut microbiota of healthy mice, was assessed. Each strain produces a different type of polymer; the ropy strain S89L synthesized a rhamnose-rich, high-molecular weight EPS in highest abundance than the non-ropy DMS10140 one. BALB/c mice were orally fed for 10 days with milk-bifidobacterial suspensions and followed afterward for 7 post-intervention days (wash-out period). The colonic content of mice was collected in several sampling points to perform a metataxonomic analysis. In addition, the influence of specific microbial clades, apparently stimulated by the ropy and non-ropy strains, on mouse plasmatic cytokine levels was investigated through hierarchical association testing. Analysis of 16S rRNA gene sequences showed that the abundance of Firmicutes phylum significantly increased 7 days after cessing the treatment with both strains. The relative abundance of Alloprevotella genus also rose, but after shorter post-treatment times (3 days for both DMS10140 and S89L strains). Some bacterial clades were specifically modulated by one or another strain. As such, the non-ropy DMS10140 strain exerted a significant influence on Intestinomonas genus, which increased after 4 post-administration days. On the other hand, feeding with the ropy strain S89L led to an increase in sequences of Faecalibaculum genus at 4 post-treatment days, while the abundance of Erysipelotrichaceae and Lactobacillaceae families increased for prolonged times. Association testing revealed that several lactobacilli and bifidobacterial significantly stimulated by ropy S89L strain were positively associated with the levels of certain cytokines, including IL-5 and IL-27. These results highlight relevant changes in mice gut microbiota produced after administration of the ropy S89L strain that were associated to a potential immune modulation effect., The MicroHealth group acknowledge the projects AGL2015- 64901-R (AEI/FEDER, UE) and RTI2018-096339-B-I00 (MCIU/AEI/FEDER, UE), as well as the grant IDI/2018/000236 from the “Plan for Research, Development and Innovation of the Principado de Asturias 2018–2020” co-financed by the European Regional Development Funds (FEDER). NC-B thanks her FPI fellowship to the MINECO (BES2013-063984). CS acknowledges his Postdoctoral research contract funded by the “Instituto de Investigación Sanitaria del Principado de Asturias” (ISPA). The CIBER-EHD was funded by the Instituto de Salud Carlos III. PDE and LH-G are predoctoral fellows from University of Granada of “Programa de Doctorado: Medicina Clínica y Salud Pública.” We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA

  • Duranti, Sabrina
  • Ruíz García, Lorena
  • Lugli, Gabriele Andrea
  • Tamés, Hector
  • Milani, Christian
  • Mancabelli, Leonardo
  • Mancino, Walter
  • Longhi, Giulia
  • Carnevali, Luca
  • Sgoifo, Andreo
  • Margolles Barros, Abelardo
  • Ventura, Marco
  • Ruas-Madiedo, Patricia
  • Turroni, Francesca
Gamma aminobutyric acid (GABA) is the principal inhibitory neurotransmitter playing a key role in anxiety and depression disorders in mammals. Recent studies revealed that members of the gut microbiota are able to produce GABA modulating the gut–brain axis response. Among members of the human gut microbiota, bifidobacteria are well known to establish many metabolic and physiologic interactions with the host. In this study, we performed genome analyses of more than 1,000 bifidobacterial strains publicly available revealing that Bifidobacterium adolescentis taxon might represent a model GABA producer in human gastrointestinal tract. Moreover, the in silico screening of human/animal metagenomic datasets showed an intriguing association/correlation between B. adolescentis load and mental disorders such as depression and anxiety. Interestingly, in vitro screening of 82 B. adolescentis strains allowed identifying two high GABA producers, i.e. B. adolescentis PRL2019 and B. adolescentis HD17T2H, which were employed in an in vivo trial in rats. Feeding Groningen rats with a supplementation of B. adolescentis strains, confirmed the ability of these microorganisms to stimulate the in vivo production of GABA highlighting their potential implication in gut–brain axis interactions., This work was funded by the EU Joint Programming Initiative—A Healthy Diet for a Healthy Life (JPI HDHL, https://www.healthydietforhealthylife.eu/) to MV (in conjunction with MIUR, Italy). IPLA was funded by the projects RTI2018-096339-B-I00 (MCIU/AEI/FEDER, UE), RTI2018-095021-J-I00 (MCIU/AEI/FEDER, UE) and IDI_2018_000236 (PCTI Govierno Principado de Asturias / FEDER); H. Tamés acknowledges the “Severo Ochoa” Research grant from the Government of “Principado de Asturias”. We thank GenProbio srl for financial support of the Laboratory of Probiogenomics. Part of this research is conducted using the High Performance Computing (HPC) facility of the University of Parma. Thanks are given to Isabel Cuesta, from the Technical Services of IPLA-CSIC, and Diana Luaces for their excellent technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microbiota-derived β-amyloid-like peptides trigger alzheimer’s disease-related pathways in the sh-sy5y neural cell line

  • Blanco-Míguez, Aitor
  • Tamés, Hector
  • Ruas-Madiedo, Patricia
  • Sánchez García, Borja
Here, we present the first in silico and in vitro evidence of Aβ-like peptides released from meaningful members of the gut microbiome (mostly from the Clostridiales order). Two peptides with high homology to the human Aβ peptide domain were synthesized and tested in vitro in a neuron cell-line model. Gene expression profile analysis showed that one of them induced whole gene pathways related to AD, opening the way to translational approaches to assess whether gut microbiota-derived peptides might be implicated in the neurodegenerative processes related to AD. This exploratory work opens the path to new approaches for understanding the relationship between the gut microbiome and the triggering of potential molecular events leading to AD. As microbiota can be modified using diet, tools for precise nutritional intervention or targeted microbiota modification in animal models might help us to understand the individual roles of gut bacteria releasing Aβ-like peptides and therefore their contribution to this progressive disease., This work was supported by the Spanish “Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad” through the projects AGL2013-44039R (MINECO, FEDER, UE) and RTI2018-096339-B-I00 (MCIU/AEI/FEDER, UE); by the “Asociación Española Contra el Cáncer” by means of the project “Obtención de péptidos bioactivos contra el Cáncer Colo-Rectal a partir de secuencias genéticas de microbiomas intestinalis” (grant PS-2016); and by the Asturias Regional Plan I+D+i for research groups (FYCYT-IDI/2018/000236). H.T. acknowledges his “Severo Ochoa” predoctoral grant (BP17-55) to the Government of “Principado de Asturias”.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Producción de bebidas fermentadas biofortificadas con riboflavina empleando cepas de Bifidobacterium longum subsp. infantis

  • Tamés, Hector
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
Resumen del trabajo presentado a la 15ª Reunión de la Red Española de Bacterias Lácticas: Bacterias Lácticas en Alimentación y Salud, celebrada en Valencia (España), los días 26 y 27 de mayo de 2022., INTRODUCCIÓN: La creciente demanda mundial de alimentos y su excesivo procesamiento muchas veces acarrea la pérdida de propiedades nutricionales de los mismos, como es el caso de la riboflavina o vitamina B2. Conociéndose la capacidad de algunas cepas de Bifidobacterium longum subsp. infantis para producir esta vitamina in vitro, su inclusión en matrices alimentarias permitiría biofortificar alimentos carentes de esta vitamina o reponer la pérdida ocasionada por procesos térmicos en la industria alimentaria. Sin embargo, el empleo de este microorganismo anaerobio estricto, que puede presentar características probióticas de interés, frecuentemente dificulta su empleo a escala industrial. OBJETIVO: Elaboración de alimentos fermentados fortificados con riboflavina producida por cepas de B. longum subsp. infantis superproductoras de esta vitamina en formato leche fermentada, bebida de almendras fermentada o bebida tipo yogurt. MATERIAL Y MÉTODOS: Hemos generado un total de nueve clones distintos superproductores de riboflavina provenientes de las cepas parentales B. longum subsp. infantis CECT4551T e IPLA4551 (un mutante espontáneo de la cepa tipo). Los dos clones con mayor producción de riboflavina en medio de cultivo (¿300 ¿g/L), denominados gRos4 y pRos7, procedentes de cada parental y que además presentaban un fenotipo de tolerancia parcial al oxígeno, se emplearon para fermentar, en condiciones aerobias, leche semidesnatada esterilizada, bebida vegetal de almendras UHT y leche desnatada UHT. En este último caso se emplearon conjuntamente fermentos comerciales de yogurt (Streptococcus thermophilus y Lactobacillus delbrueckii subsp. bulgaricus). Transcurridas 18 h de fermentación se midió el pH, se contaron las bacterias viables, empleando medios selectivos, y se cuantificó la producción de riboflavina por HPLC-FLD. RESULTADOS: Los dos clones de B. longum subsp. infantis con mayor producción de riboflavina se mantuvieron viables y conservaron la capacidad de producción de la vitamina en todas las matrices (leche y bebida vegetal de almendras) en condiciones aerobias. La matriz más apropiada es la láctea, mientras que en la bebida de almendras se produce una pérdida parcial de viabilidad (aproximadamente 1 orden de magnitud) acompañada de una menor producción de riboflavina (aproximadamente un 35% menos) en comparación con la leche. CONCLUSIONES: El creciente interés en la búsqueda de nuevos probióticos en muchas ocasiones se topa con las dificultades de cultivo o adaptación de las cepas a los entornos y matrices industriales. Los resultados obtenidos han permitido comprobar la buena aptitud tecnológica de dos cepas de B. longum subsp. infantis por su tolerancia al oxígeno y capacidad para fermentar matrices lácteas y de ciertas bebidas vegetales, para generar riboflavina como producto de su metabolismo., Proyecto RTI2018-096339-B-I00 del Ministerio de Ciencia e Innovación y Beca Severo Ochoa BP17-55 del Gobierno del Principado de Asturias
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Orally Administered Bifidobacterium adolescentis Diminishes Serum Glutamate Concentration in Mice

  • Royo, Félix
  • Tamés, Hector
  • Bordanaba‐Florit, Guillermo
  • Cabrera, Diana
  • Azparren-Angulo, María
  • Garcia-Vallicrosa, Clara
  • Margolles Barros, Abelardo
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
  • Falcón-Pérez, Juan M.
Several studies have described the contribution of glutamate-transforming microbiota to the development of chronic ailments. For instance, the blood concentration of glutamate is higher in some patients with fibromyalgia, chronic fatigue, and pain. Taking advantage of a naturally occurring strain of Bifidobacterium that is able to transform glutamate in g -aminobutyric caid (GABA), B. adolescentis IPLA60004, we designed a placebo-controlled intervention to test if the presence of this GABAproducing bifidobacteria in mice was able to impact the concentration of glutamate in the blood in comparison with the administration of other strain of the same species lacking the genes of the glutamate decarboxylase (gad) cluster. Animals were fed every day with 8 log CFU of bacteria in a sterilized milk vehicle for 14 days. Samples from feces and blood were collected during this period, and afterwards animals were sacrificed, tissues were taken from different organs, and the levels of different metabolites were analyzed by ultrahigh-performance liquid chromatography coupled to mass spectrometry. The results showed that both bacterial strains orally administered survived in the fecal content, and animals fed B. adolescentis IPLA60004 showed a significant reduction of their glutamate serum concentration, while a nonsignificant decrease was observed for animals fed a reference strain, B. adolescentis LGM10502. The variations observed in GABA were influenced by the gender of the animals, and no significant changes were observed in different tissues of the brain. These results suggest that orally administered GABA-producing probiotics could reduce the glutamate concentration in blood, opening a case for a clinical trial study in chronic disease patients., This study was funded by the Basque Government's Health Department, ref. 2015111149, and the IPLA-CSIC and received funding from the Spanish National Research plan (MCIU/AEI/FEDER, UE) grant ref. RTI2018-096339-B-I00. H. Tamés received funding from “Severo Ochoa” predoctoral grant BP17-55 (Gobierno Principado de Asturias).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Productos lácteos biofortificados con metabolitos producidos por bifidobacterias: GABA y riboflavina

  • Tamés, Hector
  • Cuesta Suárez, Isabel
  • Margolles Barros, Abelardo
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
Trabajo presentado a la 16ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Madrid (España), los días 11 y 12 de mayo de 2023., Los alimentos funcionales, aquellos que más allá de la mera nutrición ejercen un beneficio para la salud basado en evidencias científicas, constituyen un sector de interés para empresas alimentarias y/ biotecnológicas dada la alta demanda de los consumidores preocupados por mejorar su calidad de vida y salud. El efecto beneficioso tiene que ser avalado por estudios científicos que demuestren su función positiva sobre una población y una diana de acción específicas. En este sentido, la población occidental de edad avanzada puede tener carencias nutricionales asociadas, entre otros parámetros, al deterioro cognitivo y al envejecimiento de los sistemas fisiológicos (digestivo, endocrino, inmunitario etc.). Por ello, el desarrollo de leches fermentadas, que tienen un alto valor nutricional intrínseco y son más fáciles de deglutir y de digerir, suplementadas in situ con ingredientes bioactivos de origen microbiano son una herramienta útil para el desarrollo de alimentos de precisión dirigidos a la población envejecida. En este trabajo hemos estudiado la capacidad de bifidobacterias de origen intestinal humano para enriquecer de forma natural, durante su crecimiento en leche, el producto final fermentado en micronutrientes (riboflavina) o neurotransmisores (ácido gamma-aminobutírico, GABA). Inicialmente, llevamos a cabo estudios in silico para detectar las especies de bifidobacterias portadoras de genes implicados en la ruta de síntesis de riboflavina y de GABA. El resultado mostró que, entre las especies incluidas en el listado QPS (qualified presumption of safety) de la EFSA, Bifidobacterium longum subsp. infantis y Bifidobacterium adolescentis tenían el potencial de producir la vitamina B2 o el neurotransmisor, respectivamente. Posteriormente, se generó una colección de mutantes espontáneos, tras exposición a roseoflavina, de B. longum subsp. infantis capaces de producir riboflavina tanto en el medio selectivo (RAM) como MRS, cuantificando su producción mediante HPLC acoplado a un detector de fluorescencia. En paralelo, se analizó una colección de aislados de B. adolescentis para evaluar, mediante HPLC y detector PDA, las cepas con mayor capacidad para convertir el sustrato glutamato monosódico añadido al medio de cultivo MRS en GABA. Finalmente, se seleccionaron dos cepas de B. longum subsp. infantis superproductoras de riboflavina y cuatro cepas de B. adolescentis con alta capacidad de producción de GABA, para estudiar sus características probióticas y su supervivencia a la digestión gastrointestinal simulada y la liofilización. Las cepas seleccionadas se emplearon para llevar a cabo fermentaciones controladas de leche pasterizada comercial, con los suplementos requeridos según el caso, realizadas a 37ºC en presencia de oxígeno (cepas productoras de riboflavina) o en condiciones de anaerobiosis (productoras de GABA). En todos los casos se observó producción de los bioactivos de interés y una alta supervivencia de las cepas. En el caso de la riboflavina, la concentración de esta vitamina en las leches fermentadas con bifidobacterias fue significativamente mayor que la de yogures comerciales. Este estudio muestra el alto potencial biotecnológico de las cepas en estudio que pueden ser aplicadas para la elaboración de leches fermentadas biofortificadas que también serían vehículo para la administración de probióticos al mostrar una alta viabilidad en el producto tras la fermentación., Fuente de financiación: Beca ¿Severo Ochoa¿ BP17-55 y ¿Ayudas a grupos de investigación¿ (AYUD-2021-50910) del Gobierno del Principado de Asturias. Proyectos RTI2018-096339-B-I00 (MCIU/AEI/FEDER, UE) y PID2021-127362OB-I00 (MCIN/ AEI/10.13039/501100011033/ ¿FEDER Una manera de hacer Europa¿).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Absorption models based on monolayers from cellular lines or porcine duodenal organoids

  • Hevia, Arancha
  • Tamés, Hector
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
Trabajo presentado en la 8th International Conference on Food Digestion, celebrada en Porto (Portugal) del 9 al 11 de abril de 2024., Foods are essential to give us the macro- and micro-nutrients we require, but they are also carriers of bioactive compounds that can have an impact on our health beyond the nutrition. Both, nutrients and bioactive compounds, need to be (bio)accessible in the foods so that, after the intestinal digestion, they become (bio)available for their absorption, which is the first step to deliver these molecules to the target tissues where they will exert their (bio)activity. Fermented foods carry out a wide variety of nutrients and bioactive molecules; then, to understand the complex mechanisms behind their health benefits, in vitro and ex vivo models, as close as possible to the in vivo physiological state, are required. In this work we have implemented two absorption models mimicking anatomical locations of the gut, a human-colonocyte model, based on the use of commercially available cellular lines Caco2 and HT29-MTX, and a porcine-duodenal model, obtained from organoids generated from the stem cells located in the intestinal crypts of duodenal tissue excised from the carcass of piglets (Sus scrofa domestica) from the ¿Gochu Asturcelta¿ breed. Parameters determining the selective permeability of the monolayers, such as the transepithelial electrical resistance (TEER) determining the strength of the tight junctions, and the paracellular transit of a fluorescent molecule (lucifer yellow), were different, as also occurs in the two anatomical locations in an in vivo situation. In general, the TEER of mixed Caco2:HT29-MTX monolayers (ratio 70:30, 21 days post-seeding) was higher that the monolayers (5 days post-seeding) obtained from pig duodenal organoids. Concomitantly, the apparent permeability coefficient was about 10-times higher for the duodenal monolayer than for the colonic one. These results are in good agreement with the physiological situation since at the colonic location the intestinal barrier is reinforced and is less permeable as a mechanism of protection against the intestinal microbiota; however, in the small intestine which is less populated, the permeability is higher allowing the uptake of nutrients. Finally, the transport of two types of nutrients (riboflavin) and bioactive molecules (GABA) that can be synthesized by bacteria during foods fermentations, also varied between monolayers. Therefore, both models can be proposed to study the absorption of molecules that can be present in different gut niches. Porcine-duodenal organoid-derived monolayers will be useful for testing transport of food digested components, while colonocyte-derived monolayers might be applied to study the absorption of microbiota-derived molecules., This work was supported by the projects RTI2018-096339-B-I00 (funded by MCIU/AEI/FEDER, UE) and PID2021-127362OB-I00 (funded by MCIN/AEI/ 10.13039/501100011033 and by ¿ERDF A way of making Europe). The autonomic Government of Principado de Asturias also has financed this work through the AYUD-2021-50910 project (FICYT, supported by FEDER) and the predoctoral ¿Severo Ochoa¿ fellowship (BP17-55) granted by H. Tamés.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization of riboflavin-overproducing Bifidobacterium longum subsp. infantis strains selected by roseoflavin treatment

  • Tamés, Héctor
  • Cuesta, Isabel
  • Vázquez Sánchez, Xenia
  • López García, Paloma
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
Diet is the primary source of riboflavin (B2) for humans. It can also be produced by lactic acid bacteria ingested with foods and by gut microbial commensals, including some bifidobacteria. Herein an in silico analysis of potential regulatory mechanisms affecting ribD transcription and translation in Bifidobacterium longum subsp. infantis is presented. Riboflavin-overproducing strains were selected by treatment with roseoflavin of B. longum susbp. infantis CECT4551T and its spontaneous derivative IPLA60011. Whole genomes of both parental strains and the sequencing of the rib clusters of the riboflavin-overproducing ones were conducted. Punctual mutations affecting different stem-loops in the aptamer region of the FMN-riboswitch involved in the regulation of the rib expression were detected. Riboflavin overproduction of the derivative strains was confirmed through HPLC quantification in RAMc and MRSc cultures, ranging from 64.9 to 441.2 μg/L. These levels correlated to predicted secondary folding and stability of the aptamer region and/or expression platform of the rib FMN riboswitch. Safety and technological properties of the riboflavin-overproducing derivatives, in terms of antibiotic resistance profile and carbohydrate utilization capabilities, were not altered following roseoflavin exposure, thus confirming the potential aptitude of the riboflavin-overproducing derivatives to produce biofortified foods such as those formulated on dairy matrixes., This work was supported by the projects RTI2018-096339-B-I00 and PID2021-127362OB-I00 (funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”) and by AYUD2021-50910 from the autonomic Government of Principado de Asturias (FICYT, supported by FEDER). H. Tamés acknowledges his predoctoral “Severo Ochoa” fellowship (BP17-55) to the Regional Government of the Principado de Asturias and X. Vázquez acknowledges her postdoctoral research contract ITM-POSTDOC-23-05 to ISPA., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Probiotic characteristics of Lactiplantibacillus plantarum CECT 9435 and its survival and competitive properties under simulated conditions of the child gut microbiota

  • Requena, Teresa
  • Martínez-Cuesta, M. Carmen
  • Aznar, Rosa
  • Mohedano Bonillo, Mari Luz
  • López García, Paloma
  • Ruas-Madiedo, Patricia
Additional data will be made available on request., Probiotics are valuable microorganisms effective in reducing malnutrition-related infections in children. In this work, a collection of lactobacilli strains representative of traditional Andean fermented beverages was in vitro screened for their capability to survive the gastrointestinal transit, to adhere to the intestinal epithelium and to compete under simulated conditions of the child gut microbiota. The results allowed the selection of the riboflavin overproducing strain Lactiplantibacillus plantarum CECT 9435 based on its good rate of survival under in vitro gastrointestinal conditions when included in a food matrix representing the fortified food supplement Incaparina. The strain also showed good adhesion to HT29 cells producing mucus and outstanding performance in E. coli competition for the adhesion to this epithelial cell line. L. plantarum CECT 9435 gut performance was also evaluated in the child intestinal microbiota simulated in a dynamic gut model (BFBL simulator). The viability of the probiotic candidate in the gut conditions was high during the 7-day intervention period, reaching over 1 × 107 counts in each of the reactors simulating the three colonic regions. The transient viability of L. plantarum CECT 9435 within the child gut microbiota and its adhesion capacity to intestinal cells could facilitate the strain potential benefits as probiotic added to fortified supplementary foods destined to malnourished children., This work was funded by the Iberian-American Program on Science and Technology for Development (CYTED, grant number 917PTE0537). Additional funds were obtained from the Spanish State Research Agency (AEI 10.13039/501100011033) belonging to the Ministry of Science and Innovation (MCIN) and by European Regional Development Fund (FEDER, EU) through the projects PCIN2017-075, PCIN2017-003, RTI2018-097114-B-I00, RTI2018-096339-B-I00, and PID2019-106071RB-I00., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., Peer reviewed